Direct and Coordinate Regulation of ATP-binding Cassette Transporter Genes by Myc Factors Generates Specific Transcription Signatures That Significantly Affect the Chemoresistance Phenotype of Cancer Cells
Overview
Authors
Affiliations
Increased expression of specific ATP-binding cassette (ABC) transporters is known to mediate the efflux of chemotherapeutic agents from cancer cells. Therefore, establishing how ABC transporter genes are controlled at their transcription level may help provide insight into the role of these multifaceted transporters in the malignant phenotype. We have investigated ABC transporter gene expression in a large neuroblastoma data set of 251 tumor samples. Clustering analysis demonstrated a strong association between differential ABC gene expression patterns in tumor samples and amplification of the MYCN oncogene, suggesting a correlation with MYCN function. Using expression profiling and chromatin immunoprecipitation studies, we show that MYCN oncoprotein coordinately regulates transcription of specific ABC transporter genes, by acting as either an activator or a repressor. Finally, we extend these notions to c-MYC showing that it can also regulate the same set of ABC transporter genes in other tumor cells through similar dynamics. Overall our findings provide insight into MYC-driven molecular mechanisms that contribute to coordinate transcriptional regulation of a large set of ABC transporter genes, thus affecting global drug efflux.
The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis.
Murray J, Valli E, Milazzo G, Mayoh C, Gifford A, Fletcher J Nat Commun. 2024; 15(1):5585.
PMID: 38992040 PMC: 11239676. DOI: 10.1038/s41467-024-49871-0.
RPF2 mediates the CARM1‑MYCN axis to promote chemotherapy resistance in colorectal cancer cells.
Lu M, Hu X, Cheng C, Zhang Y, Huang L, Kong X Oncol Rep. 2023; 51(1).
PMID: 37997821 PMC: 10696550. DOI: 10.3892/or.2023.8670.
MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products.
Chan K, Zhang S, Li G, Xu Y, Cui L, Wang Y Aging Dis. 2023; 15(2):640-697.
PMID: 37450923 PMC: 10917530. DOI: 10.14336/AD.2023.0520.
Therapy resistance in neuroblastoma: Mechanisms and reversal strategies.
Zhou X, Wang X, Li N, Guo Y, Yang X, Lei Y Front Pharmacol. 2023; 14:1114295.
PMID: 36874032 PMC: 9978534. DOI: 10.3389/fphar.2023.1114295.
Using biological constraints to improve prediction in precision oncology.
Omar M, Dinalankara W, Mulder L, Coady T, Zanettini C, Imada E iScience. 2023; 26(3):106108.
PMID: 36852282 PMC: 9958363. DOI: 10.1016/j.isci.2023.106108.